BioAtla (BCAB) Interest Expenses (2020 - 2026)

BioAtla's Interest Expenses history runs 7 years deep, the most recent figure standing at $20000.0 for Q1 2026.

• On a quarterly basis, Interest Expenses fell 93.06% year-over-year to $20000.0 in Q1 2026; TTM through Mar 2026 was $989000.0, a 27.76% decrease from a year earlier, with the FY2025 full-year figure at $115.9 million, up 12.93% from the prior year.
• Interest Expenses slipped to $20000.0 in Q1 2026 per BCAB's latest filing, from $1.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $2.7 billion in Q3 2022 and bottomed at $5000.0 in Q4 2024.
• The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $209.9 million.
• Across the five-year window, Interest Expenses soared 738735.95% in 2022 and plunged 99.97% in 2023, its largest moves.
• Year by year, Interest Expenses stood at $400000.0 in 2022, then tumbled by 31.5% to $274000.0 in 2023, then sank by 98.18% to $5000.0 in 2024, then soared by 32320.0% to $1.6 million in 2025, then plunged by 98.77% to $20000.0 in 2026.
• Per Business Quant, the three latest BCAB Interest Expenses figures stand at $20000.0 (Q1 2026), $1.6 million (Q3 2025), and $7.9 million (Q2 2025).